Your browser doesn't support javascript.
loading
SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry.
Moritz, Rose K C; Gutzmer, Ralf; Zimmer, Lisa; Meier, Friedegund; Ahmed, Misbah S; Sell, Sabine; Schlaak, Max; Kapp, Florian; Sachse, Michael M; Haferkamp, Sebastian; Welzel, Julia; Kähler, Katharina C; Weichenthal, Michael.
Afiliação
  • Moritz RKC; Department for Dermatology and Venereology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany. Electronic address: rose.moritz@uk-halle.de.
  • Gutzmer R; Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany.
  • Zimmer L; Department of Dermatology, University Hospital Essen, Essen, Germany.
  • Meier F; Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
  • Ahmed MS; Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases Dresden, Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
  • Sell S; SRH Wald-Klinikum Gera, Gera, Germany.
  • Schlaak M; Department of Dermatology and Allergy, University Hospital, LMU München, Munich, Germany.
  • Kapp F; Department of Dermatology and Allergy, University Hospital, LMU München, Munich, Germany.
  • Sachse MM; Department of Dermatology, Allergology and Phlebology, Klinikum Bremerhaven Reinkenheide GGmbH, Bremerhaven, Germany.
  • Haferkamp S; Department of Dermatology, University Hospital of Regensburg, Regensburg, Germany.
  • Welzel J; Department of Dermatology, University Hospital Augsburg, Augsburg, Germany.
  • Kähler KC; Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Weichenthal M; Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, Germany.
Eur J Cancer ; 144: 382-385, 2021 02.
Article em En | MEDLINE | ID: mdl-33342623
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico / COVID-19 / Melanoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico / COVID-19 / Melanoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article